Anthony Vendetti
Stock Analyst at Maxim Group
(4.46)
# 263
Out of 4,873 analysts
79
Total ratings
30.99%
Success rate
58.2%
Average return
Main Sectors:
Stocks Rated by Anthony Vendetti
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
DRMA Dermata Therapeutics | Maintains: Buy | $6 → $3 | $0.63 | +376.49% | 4 | May 21, 2025 | |
NUTX Nutex Health | Maintains: Buy | $100 → $225 | $115.90 | +94.13% | 5 | May 20, 2025 | |
SRTS Sensus Healthcare | Maintains: Buy | $14 → $10 | $4.73 | +111.42% | 6 | May 19, 2025 | |
HAIN The Hain Celestial Group | Maintains: Buy | $10 → $5 | $1.67 | +199.40% | 8 | May 8, 2025 | |
AMIX Autonomix Medical | Initiates: Buy | $5 | $1.26 | +296.83% | 1 | Apr 29, 2025 | |
BIAF bioAffinity Technologies | Downgrades: Hold | n/a | $0.25 | - | 2 | Apr 1, 2025 | |
NXL Nexalin Technology | Upgrades: Buy | $5 | $1.06 | +371.70% | 3 | Mar 24, 2025 | |
SSKN STRATA Skin Sciences | Initiates: Buy | $6 | $2.31 | +159.74% | 1 | Feb 27, 2025 | |
BHST BioHarvest Sciences | Initiates: Buy | $12 | $6.90 | +73.91% | 1 | Dec 18, 2024 | |
ACON Aclarion | Downgrades: Hold | n/a | $6.80 | - | 2 | Dec 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $8 | $0.89 | +796.36% | 1 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.33 | - | 2 | Oct 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $50 | $45.41 | +10.11% | 7 | Sep 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.60 | - | 2 | Jul 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $60 | $7.32 | +719.67% | 1 | Jan 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $8.37 | +19.55% | 1 | Dec 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $0.86 | +478.90% | 1 | Oct 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $0.88 | +2,637.23% | 1 | Oct 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $11.71 | - | 4 | Aug 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2 | $2.38 | -15.97% | 1 | May 25, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $0.36 | +34,660.85% | 1 | Apr 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $7 | $0.32 | +2,122.22% | 3 | Mar 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $25 | $26.96 | -7.25% | 1 | Mar 29, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.18 | - | 1 | Mar 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $3,500 | $2.76 | +126,711.59% | 2 | Mar 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $5 | $2.53 | +97.63% | 2 | Nov 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.62 | - | 2 | Nov 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.99 | +203.06% | 1 | Oct 25, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $15.34 | - | 2 | Sep 21, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $120,000 | $4.76 | +2,520,908.40% | 3 | Nov 22, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | n/a | $43.93 | - | 3 | Jun 3, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $792 → $720 | $0.84 | +85,614.29% | 2 | Aug 16, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $10.28 | -51.36% | 1 | Jan 26, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.07 | - | 1 | May 31, 2016 |
Dermata Therapeutics
May 21, 2025
Maintains: Buy
Price Target: $6 → $3
Current: $0.63
Upside: +376.49%
Nutex Health
May 20, 2025
Maintains: Buy
Price Target: $100 → $225
Current: $115.90
Upside: +94.13%
Sensus Healthcare
May 19, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $4.73
Upside: +111.42%
The Hain Celestial Group
May 8, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.67
Upside: +199.40%
Autonomix Medical
Apr 29, 2025
Initiates: Buy
Price Target: $5
Current: $1.26
Upside: +296.83%
bioAffinity Technologies
Apr 1, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.25
Upside: -
Nexalin Technology
Mar 24, 2025
Upgrades: Buy
Price Target: $5
Current: $1.06
Upside: +371.70%
STRATA Skin Sciences
Feb 27, 2025
Initiates: Buy
Price Target: $6
Current: $2.31
Upside: +159.74%
BioHarvest Sciences
Dec 18, 2024
Initiates: Buy
Price Target: $12
Current: $6.90
Upside: +73.91%
Aclarion
Dec 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $6.80
Upside: -
Nov 15, 2024
Maintains: Buy
Price Target: $22 → $8
Current: $0.89
Upside: +796.36%
Oct 16, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.33
Upside: -
Sep 5, 2024
Maintains: Buy
Price Target: $65 → $50
Current: $45.41
Upside: +10.11%
Jul 17, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.60
Upside: -
Jan 30, 2024
Initiates: Buy
Price Target: $60
Current: $7.32
Upside: +719.67%
Dec 20, 2023
Initiates: Buy
Price Target: $10
Current: $8.37
Upside: +19.55%
Oct 5, 2023
Initiates: Buy
Price Target: $5
Current: $0.86
Upside: +478.90%
Oct 5, 2023
Initiates: Buy
Price Target: $24
Current: $0.88
Upside: +2,637.23%
Aug 11, 2023
Downgrades: Hold
Price Target: n/a
Current: $11.71
Upside: -
May 25, 2023
Initiates: Buy
Price Target: $2
Current: $2.38
Upside: -15.97%
Apr 20, 2023
Initiates: Buy
Price Target: $125
Current: $0.36
Upside: +34,660.85%
Mar 31, 2023
Maintains: Buy
Price Target: $12 → $7
Current: $0.32
Upside: +2,122.22%
Mar 29, 2023
Maintains: Buy
Price Target: $15 → $25
Current: $26.96
Upside: -7.25%
Mar 28, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.18
Upside: -
Mar 23, 2023
Maintains: Buy
Price Target: $6,000 → $3,500
Current: $2.76
Upside: +126,711.59%
Nov 15, 2022
Maintains: Buy
Price Target: $13 → $5
Current: $2.53
Upside: +97.63%
Nov 15, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.62
Upside: -
Oct 25, 2022
Initiates: Buy
Price Target: $3
Current: $0.99
Upside: +203.06%
Sep 21, 2022
Downgrades: Hold
Price Target: n/a
Current: $15.34
Upside: -
Nov 22, 2019
Upgrades: Buy
Price Target: $120,000
Current: $4.76
Upside: +2,520,908.40%
Jun 3, 2019
Upgrades: Hold
Price Target: n/a
Current: $43.93
Upside: -
Aug 16, 2018
Maintains: Buy
Price Target: $792 → $720
Current: $0.84
Upside: +85,614.29%
Jan 26, 2017
Upgrades: Buy
Price Target: $5
Current: $10.28
Upside: -51.36%
May 31, 2016
Downgrades: Hold
Price Target: n/a
Current: $7.07
Upside: -